Dr. Hu Yan, MD, PhD

Position:

· Director of Department of Gynecology, The First Affiliated Hospital of Wenzhou Medical University

· Head of the Standardized Diagnosis and Treatment of Cervical Diseases Team, The First Affiliated Hospital of Wenzhou Medical University

Institution:

· The First Affiliated Hospital of Wenzhou Medical University

Current Address:

· Department of Gynecology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang, China

· Tel: 13806696807

Education:

· 1988 - 1993: B.Sc. (Clinical Medicine), Wenzhou Medical University, China

· 1999 - 2002: M.A.Sc. (Obstetrics and Gynecology), Fudan University, China

· 2009 - 2012: Ph.D. (Obstetrics and Gynecology), Wenzhou Medical University, China

Professional History:

· 1993 - 1998: Resident Physician, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Wenzhou Medical University, China

· 1998 - 2003: Attending Physician, Lecturer, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Wenzhou Medical University, China

· 2003 - 2011: Associate Chief Physician, Associate Professor, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Wenzhou Medical University, China

· 2011 - Present: Chief Physician of Gynecology, Associate Professor, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Wenzhou Medical University, China

Teaching Experience:

· 2016: PBL Teaching Training, Zhongshan Medical College, Taiwan, China

· 2005 - 2006: Visiting Scholar, Heartlands & Solihull Hospital, Birmingham, UK, focusing on comprehensive diagnosis and treatment of gynecologic oncology

· 2004: Visiting Doctor, Department of Obstetrics and Gynecology, Medical University of Graz, Austria

Other Appointments and Affiliations:

· 2023 - Present: Member, Obstetrician and Gynecologist Branch of Chinese Medical Doctor Association

· 2022 - Present: Member, "The Belt and Road" Medical Talent Training Alliance Endoscopy (Gynecology) Committee

· 2023 - Present: Deputy Director, Obstetrics and Gynecology Branch of Zhejiang Medical Association

· 2023 - Present: Deputy Director, Reproductive Health Branch of Zhejiang Provincial Preventive Medicine Association

· 2023 - Present: Deputy Director, Gynecologic Oncology Branch of Zhejiang Medical Association

· 2023 - Present: Member, Cervical Cancer Committee of Zhejiang Provincial Tumor Diagnosis and Treatment Quality Control Center

· 2023 - Present: Member, First Session of the Robotic Surgery Professional Committee of Zhejiang Medical Association

· 2023 - Present: Director, Obstetrics and Gynecology Branch of Wenzhou Medical Association

· 2023 - Present: Deputy Director, Gynecologic Oncology Branch of Wenzhou Medical Association

Prizes, Awards, and Other Activities:

· 2023/2024: Advanced Department Head, The First Affiliated Hospital of Wenzhou Medical University

· 2023/2024: Outstanding Party Branch Secretary, The First Affiliated Hospital of Wenzhou Medical University

· 2023: Scientific Research Excellence Award, National Health Commission Science and Technology Committee

· 2023: Obstetrics and Gynecology Excellent Paper Poster Exhibition Award, Chinese Medical Doctor Association

· 2020: Outstanding Resident Standardized Training Instructor, The First Affiliated Hospital of Wenzhou Medical University

Student Supervisions & Teaching:

· 2023: "Double Leader", Teacher Party Branch Secretary Studio, Wenzhou Medical University

· 2023: Fine Project of Continuing Medical Education, Wenzhou Medical University

· 2022: Teaching Master, Wenzhou Medical University

· 2022: First Prize for Undergraduate Teaching Quality, Wenzhou Medical University

· 2020: First Prize for Teaching Achievement, Wenzhou Medical University

· 2019: Contribution Award for Undergraduate Teaching, Wenzhou Medical University

Publications (last 5 years):

1. Exploring the Mechanism of Brucea Javanica against Ovarian Cancer based on Network Pharmacology and the Influence of Luteolin on the PI3K/AKT Pathway. Comb Chem High Throughput Screen. 2024;27(1):157-6.

2. Altered vaginal cervical microbiota diversity contributes to HPV-induced cervical cancer via inflammation regulation. PeerJ. 2024;12:e17415.

3. Effects of peripheral blood neutrophil/lymphocyte ratio levels and their changes on the prognosis of patients with early cervical cancer. Front Oncol. 2023;13:1139809.

4. Relationship between vaginal microecology and human papillomavirus infection as well as cervical intraepithelial neoplasia in 2,147 women from Wenzhou, the southeast of China. Front Oncol. 2023;13:1306376.

5. Bruceine D and afatinib combination inhibits ovarian cancer cells proliferation and migration through DNA damage repair and EGFR pathway. J Investig Med. 2023;71(5):511-525. doi: 10.1177/10815589231158043.

6. Computer-aided diagnosis of cervical dysplasia using colposcopic images. Front Oncol. 2022;5. doi: 10.3389/fonc.2022.905623.

7. Risk factors associated with HPV persistence after conization in high-grade squamous intraepithelial lesion. Arch Gynecol Obstet. 2021 Sep 5.

8. Risk factors associated with the persistence of human papillomavirus after cervical excision in patients with high-grade squamous intra-epithelial neoplasia. Eur J Obstet Gynecol Reprod Biol. 2021 Nov.

9. Laparoscopic Radical Hysterectomy Results in Higher Recurrence Rate Versus Open Abdominal Surgery for Stage IB1 Cervical Cancer Patients With Tumor Size Less Than 2 Centimeter: A Retrospective Propensity Score-Matched Study. Front Oncol. 2021;11:2143-2151. doi: 10.3389/fonc.2021.683231.

10. Long noncoding RNA SNHG12 promotes the progression of cervical cancer via modulating miR-125b/STAT3 axis. J Cell Physiol. 2019;234(5):6624-6632.